Heart shield: common diabetes drug may prevent Chemo-Induced heart damage
NCT ID NCT07070765
First seen May 13, 2026 · Last updated May 15, 2026 · Updated 1 time
Summary
This study tests whether taking dapagliflozin (a drug used for diabetes) daily during chemotherapy can reduce heart damage in breast cancer patients. About 70 women with low to medium heart risk will take the drug while receiving anthracycline chemotherapy. The goal is to see if the drug helps keep the heart's energy levels healthy and prevents long-term heart problems.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cardiac Research Office, Aberdeen Royal Infirmary
RECRUITINGAberdeen, Aberdeenshire, AB25 2ZD, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Aberdeen
RECRUITINGAberdeen, AB25 2ZD, United Kingdom
Contact Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.